Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Ceriani

Showing results (131-140 of 140) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 140 results.
Blood Advances|May 10, 2022
SAKK 35/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphomaAnastasios Stathis, Ulrich Mey, Sämi Schär, et al.
EJNMMI Research|November 28, 2025
Predicting 2-year time to progression in diffuse large B cell lymphoma using 3D CNNs on whole-body PET/CT scansMaria C Ferrández, Sanne E Wiegers, Gerben J C Zwezerijnen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 3, 2024
Validation of an Artificial Intelligence-Based Prediction Model Using 5 External PET/CT Datasets of Diffuse Large B-Cell LymphomaMaria C Ferrández, Sandeep S V Golla, Jakoba J Eertink, et al.
Haematologica|January 8, 2026
Improving the predictive value of end-of-treatment PET/CT in diffuse large B-cell lymphomaAnne L Bes, Gerben J C Zwezerijnen, Martijn W Heymans, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 2024
International Benchmark for Total Metabolic Tumor Volume Measurement in Baseline <sup>18</sup>F-FDG PET/CT of Lymphoma Patients: A Milestone Toward Clinical ImplementationRonald Boellaard, Irène Buvat, Christophe Nioche, et al.
Blood|February 17, 2018
Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphomaValeria Spina, Alessio Bruscaggin, Annarosa Cuccaro, et al.
Blood|September 12, 2025
Impact of immunochemotherapy regimens on outcomes of patients with primary mediastinal B-cell lymphoma in the IELSG37 trialEmanuele Zucca, Luca Ceriani, Giovannino Ciccone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2024
Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial ResultsMaurizio Martelli, Luca Ceriani, Giovannino Ciccone, et al.
Blood|May 13, 2025
A Comprehensive Genetic Study of Classical Hodgkin Lymphoma Using Circulating Tumor DNAMaria Cristina Pirosa, Alessio Bruscaggin, Lodovico Terzi di Bergamo, et al.
Blood|October 15, 2021
Genetic and phenotypic attributes of splenic marginal zone lymphomaFerdinando Bonfiglio, Alessio Bruscaggin, Francesca Guidetti, et al.
Pageof 14

Showing results (131-140 of 140) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
Blood Advances|May 10, 2022
SAKK 35/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphomaAnastasios Stathis, Ulrich Mey, Sämi Schär, et al.
EJNMMI Research|November 28, 2025
Predicting 2-year time to progression in diffuse large B cell lymphoma using 3D CNNs on whole-body PET/CT scansMaria C Ferrández, Sanne E Wiegers, Gerben J C Zwezerijnen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 3, 2024
Validation of an Artificial Intelligence-Based Prediction Model Using 5 External PET/CT Datasets of Diffuse Large B-Cell LymphomaMaria C Ferrández, Sandeep S V Golla, Jakoba J Eertink, et al.
Haematologica|January 8, 2026
Improving the predictive value of end-of-treatment PET/CT in diffuse large B-cell lymphomaAnne L Bes, Gerben J C Zwezerijnen, Martijn W Heymans, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 2024
International Benchmark for Total Metabolic Tumor Volume Measurement in Baseline <sup>18</sup>F-FDG PET/CT of Lymphoma Patients: A Milestone Toward Clinical ImplementationRonald Boellaard, Irène Buvat, Christophe Nioche, et al.
Blood|February 17, 2018
Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphomaValeria Spina, Alessio Bruscaggin, Annarosa Cuccaro, et al.
Blood|September 12, 2025
Impact of immunochemotherapy regimens on outcomes of patients with primary mediastinal B-cell lymphoma in the IELSG37 trialEmanuele Zucca, Luca Ceriani, Giovannino Ciccone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2024
Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial ResultsMaurizio Martelli, Luca Ceriani, Giovannino Ciccone, et al.
Blood|May 13, 2025
A Comprehensive Genetic Study of Classical Hodgkin Lymphoma Using Circulating Tumor DNAMaria Cristina Pirosa, Alessio Bruscaggin, Lodovico Terzi di Bergamo, et al.
Blood|October 15, 2021
Genetic and phenotypic attributes of splenic marginal zone lymphomaFerdinando Bonfiglio, Alessio Bruscaggin, Francesca Guidetti, et al.
Pageof 14